CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Pain drugmaker Latigo outlines plans to go public

IPO/OfferingPositive
AI Analysis

Summary

Latigo, a Westlake-founded company specializing in non-opioid pain drugs targeting sodium ion channels, has announced plans to go public. The IPO announcement adds to ongoing biotech capital market activity.

Importance:5/10
Sentiment:
0.50
IPOnon-opioidsodium ion channelpain management
Related Companies

Read the original article

Published by BioPharma Dive on July 20, 2026 3:57 PM

Read Original